CD105 Expression Is a Marker of High Metastatic Risk and Poor Outcome in Breast Carcinomas: Correlations Between Immunohistochemical Analysis and Long-Term Follow-up in a Series of 929 Patients | Zendy

AI Assistant Blog Pricing

CD105 Expression Is a Marker of High Metastatic Risk and Poor Outcome in Breast Carcinomas: Correlations Between Immunohistochemical Analysis and Long-Term Follow-up in a Series of 929 Patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.